“Vaccine by Generex Generex has announced that
Post# of 36537
(Total Views: 346)
Posted On: 04/20/2020 9:25:57 PM
“Vaccine by Generex
Generex has announced that it is developing a COVID-19 vaccine following a contract from a Chinese consortium comprising of China Technology Exchange, Beijing Zhonghua Investment Fund Management, Biology Institute of Shandong Academy of Sciences and Sinotek-Advocates International Industry Development.
The company will utilise its Ii-Key immune system activation technology to produce a COVID-19 peptide for human clinical trials.
Generex will receive an upfront payment of $1m to commence the groundwork for the vaccine development and $5m licensing fee for its Ii-Key technology. It is also eligible to receive a 20% royalty on every dose of vaccine produced under the contract.”
https://www.clinicaltrialsarena.com/analysis/...cov-drugs/
Generex has announced that it is developing a COVID-19 vaccine following a contract from a Chinese consortium comprising of China Technology Exchange, Beijing Zhonghua Investment Fund Management, Biology Institute of Shandong Academy of Sciences and Sinotek-Advocates International Industry Development.
The company will utilise its Ii-Key immune system activation technology to produce a COVID-19 peptide for human clinical trials.
Generex will receive an upfront payment of $1m to commence the groundwork for the vaccine development and $5m licensing fee for its Ii-Key technology. It is also eligible to receive a 20% royalty on every dose of vaccine produced under the contract.”
https://www.clinicaltrialsarena.com/analysis/...cov-drugs/
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼